Your browser doesn't support javascript.
loading
Options for improvement of the Dutch measles vaccination schedule.
van den Hof, S; Wallinga, J; Widdowson, M-A; Conyn-van Spaendonck, M A E.
Afiliação
  • van den Hof S; Department of Infectious Diseases Epidemiology, National Institute for Public Health and The Environment, PO Box 1, Bilthoven BA 3720, The Netherlands. susan.van.den.hof@rivm.nl
Vaccine ; 21(7-8): 721-4, 2003 Jan 30.
Article em En | MEDLINE | ID: mdl-12531348
ABSTRACT
We investigated which vaccination schedule gives best protection to the vaccinating population, in case of a measles epidemic in pockets of unvaccinated individuals. We explored the effect of an additional measles vaccination (at 6 or 9 months), advancing the first measles-mumps-rubella (MMR) vaccination from 14 to 11 months, and advancing the second MMR from 9 to 4 years. Measures of protection among vaccinees (percentage of susceptibles, number of reported cases, percentage of lifetime spent susceptible) were estimated with a mathematical model of the impact of antibody level on seroconversion and immunity. Advancing the age of second MMR vaccination prevents considerably more cases among vaccinees than an extra early measles vaccination or advancing the age of first MMR vaccination.
Assuntos
Buscar no Google
Base de dados: MEDLINE Assunto principal: Esquemas de Imunização / Vacina contra Sarampo-Caxumba-Rubéola / Sarampo Idioma: En Ano de publicação: 2003 Tipo de documento: Article
Buscar no Google
Base de dados: MEDLINE Assunto principal: Esquemas de Imunização / Vacina contra Sarampo-Caxumba-Rubéola / Sarampo Idioma: En Ano de publicação: 2003 Tipo de documento: Article